During the Microbiome Connect Europe conference, held early in July in Amsterdam, Microbiomepost discussed with Anna Chwalibóg, Chief Product Officer at Integral Solutions, about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement using, in particular, CRISPR genome engineering.
Developing psychobiotic LBPs tackling the gut-brain axis
Anna Chwalibóg, Chief Product Officer at Integral Solutions, talks about the opportunity to develop next-generation microbiome-based therapeutics for mental health and cognitive enhancement.
Most recent
Gastroenterology
26 April 2024
HCPs Area
Industry
- Read more about LBP, probiotics
Gastroenterology
26 April 2024
